JW (Cayman) Therapeutics Co. Ltd (JWCTF)

JWCTF Revenue

JW (Cayman) Therapeutics Co. had revenue of 106.35M CNY in the half year ending June 30, 2025, with 21.21% growth. This brings the company's revenue in the last twelve months to 177.75M, up 2.79% year-over-year. In the year 2024, JW (Cayman) Therapeutics Co. had annual revenue of 158.22M, down -8.99%.

• Revenue (ttm): 177.75M CNY
• Revenue Growth: +2.79%
• P/S Ratio: 4.83
• Revenue / Employee: 608.73K CNY
• Employees: 292
• Market Cap: 119.87M USD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	158.22M	-15.64M	-8.99%
Dec 31, 2023	173.86M	28.15M	19.32%
Dec 31, 2022	145.70M	114.91M	373.10%
Dec 31, 2021	30.80M	-	-
Dec 31, 2020	-	-	-